Meticulous Research®—a leading market research company, published a research report titled, ‘IVD Quality Control Market Size, Share, Forecast & Trends Analysis by Offering (Product [Serum, Blood], Data Management, Service) Technology (Biochemistry, Molecular, Immunoassay) Application (cardiology, Oncology) End User – Global Forecast to 2031’

Download Free Sample Report@ https://www.meticulousresearch.com/download-sample-report/cp_id=3447?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=25-09-2024

According to this latest publication from Meticulous Research®, the IVD quality control market is projected to reach $2.28 billion by 2031, at a CAGR of 4.3% from 2024 to 2031. The growth of the IVD quality control market is driven by the rising prevalence of chronic diseases, coupled with the increasing geriatric population, growing demand for third-party quality controls, need for internal and external quality assessment reports, increasing number of clinical laboratories, growing demand for Point-of-Care (POC) and rapid diagnostics. However, stringent technical requirements and regulatory processes for quality controls restrain this market's growth.

Growing demand for multi-analyte and multi-instrument controls offers opportunities for market growth. However, evolving regulatory landscape and lack of access to quality control/quality assurance materials are the major challenges to market growth.

Key Players
Key companies operating in the IVD quality control market are Seimens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), LGC Group (U.K.), Thermo Fisher Scientific Inc. (U.S.), SERO AS (Norway), Randox Laboratories Ltd. (U.K.), QuidelOrtho Corporation (U.S.), Streck LLC (U.S.), and Microbiologics, Inc. (U.S.), and Bio-Techne Corporation (U.S.)

The IVD quality control market is segmented by Offering (Quality Control Products {Quality Control Products, by Type [Serum/Plasma-based Controls, Whole Blood-based Controls, Urine-based Controls, Other Controls], Quality Control Products, by Function [Independent Controls, Instrument-specific Controls]}, Quality Assessment Services, Data Management Solutions); Technology (Immunoassay/Immunochemistry, Biochemistry/Clinical Chemistry, Molecular Diagnostics, Hematology, Coagulation/Hemostasis, Microbiology, Other Technologies); Application (Infectious Diseases, Oncology, Cardiology, Autoimmune Disorders, Neurology, Other Applications); End User (Hospitals & Clinics, Diagnostic Laboratories, Academic Institutes & Research Laboratories, Other End Users), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

Among the technology, in 2024, the immunoassay/immunochemistry segment is expected to account for the largest share of the IVD quality control market. Immunoassay/immunochemistry advantages, such as inherent specificity, high-throughput, high sensitivity, and low cost, are driving the growth of this technology segment. Further, the increasing use of immunoassays in POC & infectious disease testing, development of novel tests, increasing usage of miniaturized devices, and rising demand for immunoassay-based tests support the increased demand for IVD quality controls for immunoassays.

Among the applications, in 2024, the infectious diseases segment is expected to account for the largest share of the IVD quality control market. The high prevalence of infectious diseases such as HIV, dengue, influenza, and pneumonia, the emergence of pandemics such as COVID-19, and supportive initiatives by public organizations to increase diagnostic testing are the factors supporting the large market share of this segment. For instance, According to UNAIDS estimates, in 2021, 38.4 million people were living with HIV globally (36.7 million adults and 1.7 million children aged 0–14 years). Additionally, in 2021, 1.5 million new cases of HIV were reported globally. This increased the usage of quality controls for infectious diseases.

Based on end user, in 2024, the hospitals & clinics segment is expected to account for the largest share of the IVD quality control market. The large market segment share is majorly attributed to the increasing prevalence of healthcare-associated infections (HAIs), the high volume of diagnostic tests conducted in hospitals, the growth in healthcare expenditure, and the expansion of hospitals and clinics in emerging markets. Additionally, during the COVID-19 pandemic, hospital admissions increased with the number of hospitals, leading to the high adoption of COVID-19 test quality controls in hospitals & clinics.

Based on geography, Asia-Pacific is expected to register the highest growth rate over the forecast period. The significantly growing IVD industry in the region with rising demand for early diagnosis from the large patient population in Asia, rising number of accredited laboratories, increasing number of hospitals and clinical pathologies, increasing healthcare spending, and improving healthcare infrastructure in the region are some of the major drivers for the growth of the Asia-Pacific market.

Buy Now@ https://www.meticulousresearch.com/Checkout/68741959?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=25-09-2024

About Meticulous Research®:
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research